Academics
follow us
  • Linkedin
  • Twitter
  • Facebook
  • Youtube
  • Instagram
Feedback
Patent Number:- IN480583

Thiazolidinedione-Indole Compounds

  • Sector: Pharmaceutical Technology,
  • IPC: A61K, C07D,
 

Need

The current invention lacks specificity regarding preferred embodiments, potentially limiting its applicability and clarity in defining its scope.

Solution

The present invention offers a composition incorporating specific compounds and carriers, aiming to inhibit pancreatic lipase effectively.

Innovation

The invention introduces novel compounds represented by Formula I, offering diverse substituent options to enhance pancreatic lipase inhibition efficacy.

Market Analysis

Market: Anti-obesity Pharmaceuticals

CAGR: High, due to increasing global obesity rates

Potential Indian Clients: Pharmaceutical companies, healthcare institutions focusing on obesity management

Why Invest?


Pancreatic Lipase

Obesity

Lipase Inhibitor

Thiazolidinedione

At a Glance


Current TRL: NA

Funded by: NA

IPC: A61K, C07D

Domain: Pharmaceutical Development for Obesity Treatment

For more information, reach out to Mr. Rajneesh Kumar, Head of the Technology Transfer Office, at tto@bits-pilani.ac.in and 01596-255515.